| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 45.79B | 48.58B | 44.26B | 43.32B | 41.88B | 41.20B |
| Gross Profit | 17.10B | 18.91B | 16.87B | 16.50B | 17.50B | 15.96B |
| EBITDA | 6.08B | 7.89B | 6.35B | 5.64B | 8.09B | 6.95B |
| Net Income | 2.29B | 3.18B | 2.48B | 2.22B | 3.25B | 3.12B |
Balance Sheet | ||||||
| Total Assets | 87.48B | 79.86B | 81.16B | 72.05B | 66.45B | 62.61B |
| Cash, Cash Equivalents and Short-Term Investments | 11.66B | 10.77B | 12.96B | 10.49B | 11.45B | 9.45B |
| Total Debt | 9.46B | 8.79B | 9.81B | 11.08B | 7.02B | 8.19B |
| Total Liabilities | 23.81B | 21.32B | 23.71B | 22.15B | 18.53B | 18.95B |
| Stockholders Equity | 52.45B | 48.60B | 47.73B | 42.84B | 41.42B | 38.68B |
Cash Flow | ||||||
| Free Cash Flow | 549.00M | 248.00M | 2.99B | -2.06B | 4.38B | 3.07B |
| Operating Cash Flow | 6.12B | 5.67B | 8.34B | 1.06B | 6.14B | 5.38B |
| Investing Cash Flow | -4.51B | -6.55B | -3.95B | -7.04B | -3.57B | -2.69B |
| Financing Cash Flow | -685.00M | -1.88B | -2.07B | 2.29B | -1.85B | -424.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥38.34B | 9.56 | ― | 1.90% | -0.75% | 6.26% | |
74 Outperform | ¥35.19B | 15.61 | ― | 3.70% | 21.29% | 38.48% | |
70 Outperform | ¥60.80B | -468.17 | ― | 4.37% | -3.52% | 3.66% | |
69 Neutral | ¥55.25B | 13.50 | ― | 2.92% | -5.24% | 17.53% | |
66 Neutral | ¥41.96B | 35.78 | ― | 3.24% | 4.87% | -44.55% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥40.24B | 11.77 | ― | 2.37% | -8.16% | -39.90% |